MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $417,000 | +10.0% | 164,091 | -12.1% | 0.00% | – |
| Q1 2020 | $379,000 | -21.5% | 186,693 | -16.5% | 0.00% | – |
| Q4 2019 | $483,000 | +29.8% | 223,559 | -7.5% | 0.00% | – |
| Q3 2019 | $372,000 | -58.6% | 241,557 | +11.7% | 0.00% | – |
| Q2 2019 | $898,000 | +413.1% | 216,278 | +415.3% | 0.00% | – |
| Q1 2019 | $175,000 | +45.8% | 41,971 | 0.0% | 0.00% | – |
| Q4 2018 | $120,000 | -77.9% | 41,971 | -22.9% | 0.00% | – |
| Q3 2018 | $544,000 | +837.9% | 54,418 | +260.4% | 0.00% | – |
| Q1 2018 | $58,000 | -52.8% | 15,100 | 0.0% | 0.00% | – |
| Q4 2017 | $123,000 | +38.2% | 15,100 | 0.0% | 0.00% | – |
| Q3 2017 | $89,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |